Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?

Name: Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?
Creator: Nial Wheate
Published: 2019-04-20T08:59:48.177Z
Keywords: Oncology

Wheate, Nial; Armstrong-Gordon, Evangeline; Um, Irene; Gnjidic, Danijela; Moussa, Yvonne

doi:10.17632/dhjfv9n8d2.1

Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?

Published: 20 April 2019| Version 1 | DOI: 10.17632/dhjfv9n8d2.1

Contributors:

Nial Wheate, Evangeline Armstrong-Gordon, Irene Um, Danijela Gnjidic, Yvonne Moussa

Description

Summary of EviQ (Australian) chemotherapy protocols that recommend a platinum drug (Cisplatin, carboplatin, oxaliplatin).

Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?

Description

Files

Categories

Licence